✦ LIBER ✦

PDB9 Cost-Effectiveness Analysis of Saxagliptin in the Treatment of Type 2 Diabetes Mellitus in Russia

✍ Scribed by E.E. Arinina; M. Rashyd

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB53 Cost-Effectiveness of Saxagliptin

✍ A. Juarez-Garcia; D. Casalvolone; L. Qatami; K. Bergenheim; B.M.K. Donato 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PDB37 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ K Kolasa; M Niewada; J Puelles Fernandez de Troconiz; R Townsend; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB39 Cost-Effectiveness of Saxagliptin

✍ Hutchings, A.; Tolley, K.; Achana, F.; Brereton, N.J.; Lebmeier, M.; Mesa, O.A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-effectiveness of saxagliptin (Ongly

✍ Granström, Ola; Bergenheim, Klas; McEwan, Phil; Sennfält, Karin; Henriksson, Mar 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 602 KB